Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (341-350 of 430) with videos related to

Pageof 43
Sort By:
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
The Lancet. Respiratory Medicine|December 8, 2014
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trialAlberto Papi, Brunilda Marku, Nicola Scichilone, et al.
Pragmatic and Observational Research|January 26, 2024
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICSDavid Price, William Henley, José Eduardo Delfini Cançado, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2026
Mucus Plug Formation is Associated with Eosinophilic Activation in Chronic Obstructive Pulmonary DiseaseFederico Baraldi, Jordina S Y Mah, Abdulrahman Almuhanna, et al.
American Journal of Respiratory and Critical Care Medicine|October 15, 2024
Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?Daniel C Belz, Nirupama Putcha, Patricia Alupo, et al.
Human Vaccines & Immunotherapeutics|July 17, 2024
Public health management of pertussis in adults: Practical challenges and future strategiesC Raina MacIntyre, Jaime Correia de Sousa, Ulrich Heininger, et al.
The Lancet. Respiratory Medicine|September 12, 2020
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trialLaurie A Lee, Zelie Bailes, Neil Barnes, et al.
The European Respiratory Journal|July 22, 2017
Blood eosinophil count and exacerbation risk in patients with COPDMarjan Kerkhof, Samatha Sonnappa, Dirkje S Postma, et al.
Human Vaccines & Immunotherapeutics|April 2, 2024
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendationsPeter Kardos, Jaime Correia de Sousa, Ulrich Heininger, et al.
Pageof 43

Showing results (341-350 of 430) with videos related to

Sort By:
Pageof 43
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
The Lancet. Respiratory Medicine|December 8, 2014
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trialAlberto Papi, Brunilda Marku, Nicola Scichilone, et al.
Pragmatic and Observational Research|January 26, 2024
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICSDavid Price, William Henley, José Eduardo Delfini Cançado, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2026
Mucus Plug Formation is Associated with Eosinophilic Activation in Chronic Obstructive Pulmonary DiseaseFederico Baraldi, Jordina S Y Mah, Abdulrahman Almuhanna, et al.
American Journal of Respiratory and Critical Care Medicine|October 15, 2024
Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?Daniel C Belz, Nirupama Putcha, Patricia Alupo, et al.
Human Vaccines & Immunotherapeutics|July 17, 2024
Public health management of pertussis in adults: Practical challenges and future strategiesC Raina MacIntyre, Jaime Correia de Sousa, Ulrich Heininger, et al.
The Lancet. Respiratory Medicine|September 12, 2020
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trialLaurie A Lee, Zelie Bailes, Neil Barnes, et al.
The European Respiratory Journal|July 22, 2017
Blood eosinophil count and exacerbation risk in patients with COPDMarjan Kerkhof, Samatha Sonnappa, Dirkje S Postma, et al.
Human Vaccines & Immunotherapeutics|April 2, 2024
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendationsPeter Kardos, Jaime Correia de Sousa, Ulrich Heininger, et al.
Pageof 43